Reading how cells respond
The platform measures human cells over time after exposure to compounds. Computer vision turns thousands of observed features into structured signatures used to identify drug candidates and investigate how they work.
Preparing cancer programmes
At the announcement, its lead acute myeloid leukaemia candidate was on track for a 2026 IND filing. A second candidate for solid tumours was entering IND-enabling studies.
Where the funding goes
- Complete IND-enabling work and support clinical trials for two oncology programmes.
- Advance non-oncology candidates and expand the screening platform.